Stay updated on Faricimab in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:09:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    - Added Publication citation: Pitcher JD 3rd, Koh AHC, Tan CS, Vakharia P, Dagincourt N, Patel S, Yang M, Margaron P, Gallego-Pinazo R. Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration. JAMA Ophthalmol. 2026 Feb 19:e256365. Online ahead of print.
    Difference
    0.0%
    Check dated 2026-02-27T16:00:52.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Minor internal revision from v3.4.1 to v3.4.2 with no user-facing changes to study content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T07:36:44.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page shows a site revision from v3.4.0 to v3.4.1. No changes to study content, eligibility criteria, or results are visible.
    Difference
    0.0%
    Check dated 2026-02-05T14:22:03.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Minor UI/metadata updates were applied, including enabling the glossary display and updating to revision v3.4.0, with removal of older QC status text and references to No FEAR Act data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T09:28:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed. This update does not alter study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-01-14T03:15:31.000Z thumbnail image

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.